Melatonin Viatris

Melatonin, the active ingredient in Melatonin Viatris, is a melatonin receptor agonist presented as an oral dosage form for oral use. It is used to help regulate sleep patterns in adults experiencing insomnia, jet lag, or other sleep‑wake rhythm disturbances.

GNH USA supplies Melatonin Viatris as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Melatonin Viatris belongs to the melatonin receptor agonist class and is indicated for disorders of the sleep‑wake cycle.

- Insomnia: helps initiate and maintain sleep in individuals with difficulty falling or staying asleep. - Jet lag: assists in adjusting circadian rhythms after rapid travel across time zones. - Sleep‑wake rhythm disorders: supports normalization of abnormal sleep patterns such as delayed sleep phase syndrome.

Melatonin Viatris may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Drowsiness or daytime sleepiness - Headache - Dizziness - Nausea or stomach discomfort - Vivid dreams or nightmares - Mild irritability

Serious or Rare Side Effects: - Allergic reactions such as rash, itching, or swelling - Severe hypersensitivity including anaphylaxis - Breathing difficulties or wheezing - Mood changes including depression or anxiety worsening - Unusual bleeding or bruising

When considering Melatonin Viatris, several safety measures should be observed.

- Assess underlying conditions: evaluate for depression, seizure disorders, or autoimmune disease before use. - Review concurrent medications: consider potential interactions with anticoagulants, CNS depressants, or hormonal therapies. - Monitor in the elderly: start with the lowest effective dose and watch for excessive sedation. - Avoid driving or operating machinery: ensure adequate alertness before engaging in such activities. - Store below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Melatonin Viatris can interact with other medicines, requiring attention to avoid reduced efficacy or increased risk.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): may increase bleeding risk. - CNS depressants (e.g., benzodiazepines, alcohol): additive sedation. - Immunosuppressants (e.g., cyclosporine): may diminish immunosuppressive effect.

Moderate Interactions (Monitor Closely): - Caffeine-containing products: may blunt melatonin’s sleep‑promoting action. - Oral contraceptives: potential alteration of hormone levels. - Selective serotonin reuptake inhibitors (SSRIs): possible increase in serotonergic activity.